Skip to main content

Table 2 Comparision between mucosal healing group (MH Group) and non-mucosal healing group (NMH Group) at the end of TAC

From: Relationship between mucosal healing by tacrolimus and relapse of refractory ulcerative colitis: a retrospective study

  MH Group
n = 41
NMH Group
n = 14
p-value
TAC at the end of data
 CAI 2.8 (1–4) 2.7 (1–4) 0.741
 Hb (g/dl) 11.7 (9.6–15.6) 13.2 (11–15.8) 0.098
 Alb (g/dl) 3.8 (3–4.7) 3.8 (2.9–4.6) 0.703
 CRP (mg/dl) 0.12 (0.04–1.15) 0.15 (0.03–1.03) 0.665
 Mayo score 0.63 (0–1) 2.21 (2–3) 0.001
 UCEIS score 1.19 (0–4) 4.42 (4–5) 0.001
Total prednisolone dose during hospitalization (mg) 685 (330–1690) 755 (335–1322) 0.501
Duration of TAC (days) 297.6 (58–922) 136.9 (70–373) 0.014
Combined use of AZA (yes / no) 34/7 11/3 0.715
Steroid free rate at 24 weeks
n (%)
35 (85.3%) 7 (50%) 0.012
  1. Data are expressed as the mean ± standard deviation or the number of patients
  2. AZA azathioprine